Click here to jump to the main content
ACART Home.

Advisory Committee on Assisted Reproductive Technology



Health Committees | Accessibility | Site Map | Contact Us

 
Print this   Email this

Consultation


Consultation on Draft Guidelines for the Use of Preimplantation Genetic Diagnosis with Human Leukocyte Antigen Testing

 The closing date for submissions is 5 September 2008.

In 2007, ACART consulted on a range of issues, including preimplantation genetic diagnosis (PGD). ACART has since recommended that the restriction on the use of PGD with human leukocyte antigen (HLA) tissue typing for genetic conditions be removed, so that it may be used for conditions that are not inherited, for example, leukaemia. ACART also recommended that the possible use of the procedure be extended to benefit close relatives rather than restricted ot genetic siblings. These recommendations have been accepted by the Associate Minister of Health.

In May 2008, ACART provided advice to the Associate Minister of Health of PGD as required by section 38 of the Human Assisted Reproductive Technology Act 2004.
Read ACART's advice to the Associate Minister (Word, 202 KB)

ACART is now consulting on draft guidelines for PGD with HLA tissue typing. These guidelines will be used by the Ethics Committee on Assisted Reproductive Technology in considering and determining applications to use the procedure.

Document availability


The consultation document, including how to make a submission, is available in Word and PDF formats below

Consultation on Draft Guidelines for the Use of Preimplantation Genetic Diagnosis with Human Leukocyte Antigen Testing (Word, 348 KB)

Consultation on Draft Guidelines for the Use of Preimplantation Genetic Diagnosis with Human Leukocyte Antigen Testing (PDF, 172 KB)


ACART welcomes your views. The closing date for submissions is 5 September 2008.



Legal | newzealand.govt.nz | Minister of Health